(Q35772032)

English

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain

scientific article published on 25 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Orthoebolavirus zairense

0 references

object named as

Jens H Kuhn

6

0 references

author name string

Wu Ou

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Josie Delisle

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Jerome Jacques

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Joanna Shih

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Graeme Price

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Vivian Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Daniela Verthelyi

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Gerardo Kaplan

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Carolyn A Wilson

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

25 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Virology Journal

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

DNA vaccines: an historical perspective and view to the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Recent advances in Ebolavirus vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Prospects for immunisation against Marburg and Ebola viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Virus-like particles as particulate vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

DNA vaccines for biodefense

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Phenylalanines at positions 88 and 159 of Ebolavirus envelope glycoprotein differentially impact envelope function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

The coming of age of virus-like particle vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Ebolavirus and Marburgvirus: insight the Filoviridae family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Epitopes required for antibody-dependent enhancement of Ebola virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Virus-like particles: flexible platforms for vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Comprehensive analysis of ebola virus GP1 in viral entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Ebola virus: from discovery to vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

kat: a high-efficiency retroviral transduction system for primary human T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

27 July 2018

Progress in filovirus vaccine development: evaluating the potential for clinical use.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Covalent modifications of the ebola virus glycoprotein

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Ebola virus-like particles protect from lethal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3284443

25 September 2018

Development of more efficient and effective DNA vaccines

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-32

21 January 2018

Identifiers

10.1186/1743-422X-9-32

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35772032&oldid=2094828589"